Peter Cooper works for the Weinberg Group, a consulting company that helps clients on regulatory approval of products and public relations.
A biographical note promoting a March 2007 presentation by Cooper on pharmaceuticals policy in the European Union describes him as "one of the leading experts on European regulation of pharmaceuticals, biologics and therapeutic biotech products having been involved in regulatory matters for close to 30 years including serving as a Director of Regulatory Affairs for both Amgen and Medeva. Dr. Cooper, whose Ph.D. studies focused on metabolism and protein binding of drugs, has been an independent consultant since 1996 and, in September 2006, helped open THE WEINBERG GROUP's Edinburgh office." 
- The Weinberg Group Invites You to a Breakfast Briefing", March 2007.
|This article is a stub. You can help by expanding it.|